USANA Health Sciences Inc ( (USNA) ) has released its Q1 earnings. Here is a breakdown of the information USANA Health Sciences Inc presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
USANA Health Sciences, Inc. is a company that develops and manufactures high-quality nutritional supplements, functional foods, and personal care products, operating primarily in the direct selling industry with a significant presence in the Asia Pacific region. In its first quarter of 2025, USANA reported net sales of $250 million, marking a 10% increase from the previous year, despite a challenging macroeconomic environment. However, net earnings fell to $9.4 million from $16.5 million, reflecting a 43% decline, while the company maintained its full-year outlook. Key financial metrics revealed a mixed performance with adjusted diluted EPS at $0.73, down from $0.86, and adjusted EBITDA at $30 million, a 10% decrease from the prior year. The company highlighted the growth of its Hiya direct-to-consumer business, which contributed significantly to net sales and subscriber growth. Looking ahead, USANA remains confident in its growth strategy, focusing on expanding its direct selling and Hiya businesses, while navigating potential challenges from international trade policies and tariffs.